Almirall acquires US skin medications from Allergan for $550m
Spanish pharma company Almirall has completed its $550 million acquisition of five skin medications from Allergan’s Medical Dermatology unit in
Continue readingCoverage of Global Pharma Industry News
Spanish pharma company Almirall has completed its $550 million acquisition of five skin medications from Allergan’s Medical Dermatology unit in
Continue reading